|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2010-1-1
|
|
pubmed:abstractText |
The core protein of hepatitis B virus encompasses B- and T-cell immunodominant epitopes and subdivided into two domains: the N-terminal and the functional C-terminal consisted phosphorylation sites. Mutations of the core gene may change the conformation of the core protein or cause alteration of important epitopes in the host immune response. In this study twenty nine men (mean age 40 +/- 9 years old) with chronic hepatitis B were recruited for direct sequencing of the core gene. Serum ALT and HBV DNA level were measured at the time of liver biopsy. The effects of core protein mutations on patients' characteristics and subsequently mutations in B cell, T helper and cytotoxic T lymphocyte (CTL) epitopes and also C-terminal domain of core protein on the activity of liver disease was evaluated. Liver fibrosis was significantly increased in patients with core protein mutation (1.0 +/- 0.8 vs 1.9 +/- 1.4 for mean stage of fibrosis P = 0.05). Mutations in CTL epitopes and in phosphorylation sites of C-terminal domain of core protein also were associated with higher liver fibrosis (P = 0.003 and P = 0.04; Fisher's exact test for both). Patients with mutation in C-terminal domain had higher serum ALT (62 +/- 17 vs 36 +/- 12 IU/l, p = 0.02). Patients with mutations in B cell and T helper epitopes did not show significant difference in the clinical features. Our data suggests that core protein mutations in CTL epitopes and C-terminal domain accompanied with higher stage of liver fibrosis may be due to alterations in the function of core protein.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-10394365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-10751335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-10861276,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-11509871,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-11988757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-12029639,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-12566704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-12805415,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-15951426,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-16014942,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-1602535,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-16247012,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-16280547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-1711541,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-17135319,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-1717713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-17973991,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-1832236,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-18507754,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-18652653,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-18984463,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-19031457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-7520091,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-8196768,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-8707278,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-8780574,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-9059940,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-9275161,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19939285-9672136
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1743-422X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
209
|
|
pubmed:dateRevised |
2010-9-27
|
|
pubmed:meshHeading |
pubmed-meshheading:19939285-Adult,
pubmed-meshheading:19939285-Antigens, CD13,
pubmed-meshheading:19939285-DNA, Viral,
pubmed-meshheading:19939285-Epitopes, T-Lymphocyte,
pubmed-meshheading:19939285-Hepatitis B, Chronic,
pubmed-meshheading:19939285-Hepatitis B virus,
pubmed-meshheading:19939285-Humans,
pubmed-meshheading:19939285-Liver Cirrhosis,
pubmed-meshheading:19939285-Male,
pubmed-meshheading:19939285-Mutation,
pubmed-meshheading:19939285-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:19939285-Viral Core Proteins
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The role of mutations in core protein of hepatitis B virus in liver fibrosis.
|
|
pubmed:affiliation |
National Institute of Genetic Engineering and Biotechnology Tehran, Iran. ashraf@ams.ac.ir
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
